ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2174

Neutrophils in Primary Antiphospholipid Syndrome Are Characterized By a Prominent Activated Phenotype and Uniquely Remodeled Chromatin Architecture

Patrick Coit, Srilakshmi Yalavarthi, Jason S. Knight and Amr H. Sawalha, Division of Rheumatology, University of Michigan, Ann Arbor, MI

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: antiphospholipid syndrome, DNA Methylation, epigenetics and neutrophils, Gene Expression

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Antiphospholipid Syndrome: Basic Science

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by recurrent thrombotic events, pregnancy complications, and the presence of antiphospholipid antibodies. The pathogenesis of primary APS is incompletely understood. We aimed to investigate the role of neutrophils in primary APS.

Methods: We studied 19 patients with primary APS and 19 healthy controls matched for age, sex, and ethnicity. Neutrophils were extracted from peripheral blood samples using density gradient centrifugation followed by flow cytometry to confirm neutrophil purity. A comprehensive transcriptome analysis was performed using paired-end 100bp mRNA sequencing reads generated on an Illumina HiSeq 2000 instrument. A genome-wide DNA methylation analysis was performed using Infinium HumanMethylation450 BeadChip arrays. RNA sequencing data were normalized and analyzed following quality control assessment and filtering using EdgeR software package in the R programming environment. Differential gene expression between patients and controls was defined using a fold difference of >2 and a false discovery rate <0.01. DNA methylation analysis was performed using GenomeStudio (Illumina) and differentially methylated loci between patients and controls were identified using an absolute methylation difference of at least 10% and a P value <0.01 after correction for multiple testing. Bioinformatics analysis was performed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID), and Ingenuity Pathway Analysis. 

Results: RNA sequencing analysis identified 593 overexpressed and 769 underexpressed genes in neutrophils from primary APS patients compared to age, sex, and ethnicity matched healthy controls. Neutrophils in primary APS are characterized by a pro-inflammatory phenotype defined by prominent transcriptional overexpression of interferon-regulated genes such as IFIT1 (8-fold), IFIT3 (5-fold), IFI6 (5-fold), MX1 (5-fold), HERC5 (5-fold), IFIT2 (5-fold), and ISG15 (4-fold), among many others. Neutrophils from primary APS patients are also characterized by activation of the Toll-like receptor signaling pathway with overexpression of TLR4, TLR5, and TLR8 (2-3 folds). In addition, neutrophils from patients overexpressed several Fc-gamma receptors including FCGR1A, FCGR1B, FCGR2A, FCGR3A, and FCGR3B (2.5-3.5 folds). P-selectin glycoprotein ligand-1 (PSGL-1) and L-selectin (CD62L), which play an important role in neutrophil adhesion to the vessel wall and neutrophil degranulation, were both also overexpressed in primary APS neutrophils. DNA methylation analysis in neutrophils from primary APS suggests an epigenetic architecture that is unique and very distinct from lupus neutrophils. Indeed, DNA methylation profiles in a small number of specific CG sites are very sensitive and specific to stratify patients with primary APS versus lupus with an area under the ROC curve of ≥0.90.

Conclusion: Neutrophils in patients with primary APS are activated and likely play an important role in disease pathogenesis. Further, the DNA methylation signature in primary APS neutrophils suggests a unique epigenetic architecture that is distinctly dissimilar from lupus.


Disclosure: P. Coit, None; S. Yalavarthi, None; J. S. Knight, None; A. H. Sawalha, None.

To cite this abstract in AMA style:

Coit P, Yalavarthi S, Knight JS, Sawalha AH. Neutrophils in Primary Antiphospholipid Syndrome Are Characterized By a Prominent Activated Phenotype and Uniquely Remodeled Chromatin Architecture [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/neutrophils-in-primary-antiphospholipid-syndrome-are-characterized-by-a-prominent-activated-phenotype-and-uniquely-remodeled-chromatin-architecture/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neutrophils-in-primary-antiphospholipid-syndrome-are-characterized-by-a-prominent-activated-phenotype-and-uniquely-remodeled-chromatin-architecture/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology